CARDIAC EVENTS AFTER ANTI-BCMA CHIMERIC ANTIGEN RECEPTOR T-CELL (IDECABTAGENE VICLEUCEL) FOR MULTIPLE MYELOMA

被引：0
|
作者：
Lee, Dae Hyun
Chandrasekhar, Sanjay Amrith
Jain, Michael
Hansen, Doris
Freeman, Ciara
Alsina, Melissa
Baz, Rachid
Puglianini, Omar Castaneda
Liu, Hien
Blue, Brandon
Davila, Marco L.
Faramand, Rawan
Kumar, Abhishek
Shah, Bijal
Lazaryan, Aleksandr
Khimani, Farhad
Nishihori, Taiga
Bachmeier, Christina
Locke, Frederick
Oliveira, Guilherme Henrique
Alomar, Mohammed
机构：
[1] Univ S Florida, Tampa, FL 33620 USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2022年 / 79卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1933 / 1933
页数：1
相关论文
共 50 条
  • [1] Real world experience of patients treated with idecabtagene vicleucel: a BCMA-directed chimeric antigen receptor T-cell therapy for multiple myeloma
    Canonico, Dalton
    Laubach, Jacob
    Mo, Clifton
    Sperling, Adam
    Nikiforow, Sarah
    Redd, Robert
    Ramsdell, Linda
    McDermott, Kathleen
    Finn, Kathleen
    Desnoyers, Lauren
    Jacobson, Caron
    Bianchi, Giada
    Midha, Shonali
    Hartley-Brown, Monique
    Ghobrial, Irene
    Anderson, Kenneth
    Munshi, Nikhil
    Nadeem, Omar
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S39 - S39
  • [2] Idecabtagene vicleucel chimeric antigen receptor T-cell therapy for relapsed/refractory multiple myeloma with renal impairment
    Sidana, Surbhi
    Peres, Lauren C.
    Hashmi, Hamza
    Hosoya, Hitomi
    Ferreri, Christopher
    Khouri, Jack
    Dima, Danai
    Atrash, Shebli
    Voorhees, Peter
    Simmons, Gary
    Sborov, Douglas W.
    Kalariya, Nilesh
    Hovanky, Vanna
    Bharadwaj, Sushma
    Miklos, David
    Wagner, Charlotte
    Kocoglu, Mehmet H.
    Kaur, Gurbakhash
    Davis, James A.
    Midha, Shonali
    Janakiram, Murali
    Freeman, Ciara
    Alsina, Melissa
    Locke, Frederick
    Gonzalez, Rebecca
    Lin, Yi
    Mcguirk, Joseph
    Afrough, Aimaz
    Shune, Leyla
    Patel, Krina K.
    Hansen, Doris K.
    [J]. HAEMATOLOGICA, 2024, 109 (03) : 777 - 786
  • [3] Lenalidomide Enhances Anti-BCMA Chimeric Antigen Receptor T Cell Function Against Multiple Myeloma
    Works, Melissa
    Soni, Neha
    Hauskins, Collin
    Sierra, Catherine
    Baturevych, Alex
    Jones, Jon
    Curtis, Wendy
    Johnstone, Timothy
    Kugler, David
    Jiang, Yue
    Hause, Ron
    Sather, Blythe Duke
    Salmon, Ruth
    Ports, Michael
    [J]. BLOOD, 2017, 130
  • [4] Cardiovascular events during treatment with anti-BCMA chimeric antigen receptor T-cells in multiple myeloma
    Mathilde, Chanut
    [J]. HEMATOLOGIE, 2023, 29 (05): : 274 - 275
  • [5] In vivo expansion patterns of anti-BCMA CAR T-cell in relapsed/refractory multiple myeloma: Comparative immunomonitoring of idecabtagene vicleucel and ciltacabtagene autoleucel
    Kocoglu, Mehmet
    Rapoport, Aaron P.
    Gebru, Etse
    Omili, Destiny
    Yamoah, Daniel
    Mulatu, Rediet
    Yared, Jean
    Hardy, Nancy M.
    Kallen, Michael
    Badros, Ashraf Z.
    Atanackovic, Djordje
    [J]. CANCER RESEARCH, 2024, 84 (06)
  • [6] Comprehensive meta-analysis of anti-BCMA chimeric antigen receptor T-cell therapy in relapsed or refractory multiple myeloma
    Zhang, Lina
    Shen, Xuxing
    Yu, Wenjun
    Li, Jing
    Zhang, Jue
    Zhang, Run
    Li, Jianyong
    Chen, Lijuan
    [J]. ANNALS OF MEDICINE, 2021, 53 (01) : 1547 - 1559
  • [7] Idecabtagene vicleucel chimeric antigen receptor T-cell therapy for relapsed and refractory multiple myeloma: real-world experience
    Hansen, Doris
    Sidana, Surbhi
    Peres, Lauren
    Leitzinger, Christelle Colin
    Shune, Leyla
    Shrewsbury, Alexandria
    Gonzalez, Rebecca
    Sborov, Douglas
    Wagner, Charlotte
    Hashmi, Hamza
    Kocoglu, Mehmet
    Atrash, Shebli
    Simmons, Gary
    Kalariya, Nilesh
    Ferreri, Christopher
    Afrough, Aimaz
    Kansagra, Ankit
    Voorhees, Peter
    Baz, Rachid
    Khouri, Jack
    Alsina, Melissa
    McGuirk, Joseph
    Locke, Frederick
    Patel, Krina
    [J]. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S2 - S3
  • [8] Anti-BCMA CAR T-Cell Therapy in Multiple Myeloma
    Quintas-Cardama, Alfonso
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (03):
  • [9] Cost-Effectiveness of Anti-BCMA Chimeric Antigen Receptor T Cell Therapy in Relapsed/Refractory Multiple Myeloma
    Yamamoto, Chihiro
    Minakata, Daisuke
    Yokoyama, Daizo
    Furuki, Shuka
    Noguchi, Atsuto
    Koyama, Shunsuke
    Oyama, Takashi
    Murahashi, Rui
    Nakashima, Hirotomo
    Ikeda, Takashi
    Kawaguchi, Shin-ichiro
    Hyodo, Kazuki
    Toda, Yumiko
    Ito, Shoko
    Nagayama, Takashi
    Umino, Kento
    Morita, Kaoru
    Ashizawa, Masahiro
    Ueda, Masuzu
    Hatano, Kaoru
    Sato, Kazuya
    Ohmine, Ken
    Fujiwara, Shin-ichiro
    Kanda, Yoshinobu
    [J]. TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (01): : 118.e1 - 118.e15
  • [10] Idecabtagene Vicleucel Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Multiple Myeloma with Renal Insufficiency: Real World Experience
    Sidana, Surbhi
    Peres, Lauren C.
    Hashmi, Hamza
    Hosoya, Hitomi
    Ferreri, Christopher J.
    Atrash, Shebli
    Khouri, Jack
    Voorhees, Peter M.
    Dima, Danai
    Simmons, Gary
    Kalariya, Nilesh
    Hovanky, Vanna
    Bharadwaj, Sushma
    Arai, Sally
    Miklos, David B.
    Wagner, Charlotte B.
    Davis, James
    Sborov, Douglas W.
    Nishihori, Taiga
    Alsina, Melissa
    Locke, Frederick L.
    Gonzalez, Rebecca
    Kocoglu, M. Hakan
    Sannareddy, Aishwarya
    Afrough, Aimaz
    McGuirk, Joseph P.
    Shune, Leyla O.
    Patel, Krina
    Hansen, Doris K.
    [J]. BLOOD, 2022, 140 : 10377 - 10379
12345